The moment of truth has arrived: it is time to close the round. The deal lead and founders worked hard together to line up investors, negotiate terms, work through deal documents and disclosure schedules, and track down every last detail of cap tables. As usual it took longer than expected, everyone is exhausted and the company needs the money urgently to make long-postponed investments in growth.
- Delta Development Team Equips Kenosha WI EMS Carry Blood to the Frontline
- NuvOx Announces Positive Results 1st Cohort Phase Ib Trial
- Tech Parks Arizona Economic Impact
- Delta Development Team Exceeds New Prehospital Blood Transfusion Standards
- Clinical Trial Confirms GammaTile Superior Tumor Control
- 2025 Brutal Biotech Investment Climate
- Delta Development Team – Introducing BloodCOMM Premium
- Special Operations Forces Blood Cooler from Delta Development
- UACI startup alumni Reglagene making impressive strides in brain cancer treatment
- Reglagene RGN6024 Cover Story August 2025 Molecular Cancer Therapeutics